enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Ticagrelor - Wikipedia

    en.wikipedia.org/wiki/Ticagrelor

    In the US, ticagrelor is indicated to reduce the risk of stroke in people with acute ischemic stroke or high-risk transient ischemic attack. [5]In the EU, ticagrelor, co-administered with acetylsalicylic acid (aspirin), is indicated for the prevention of atherothrombotic events in adults with acute coronary syndromes or a history of myocardial infarction and a high risk of developing an ...

  3. BRILINTA (Ticagrelor) Receives Additional Class I ... - AOL

    www.aol.com/news/2012-12-17-brilinta-ticagrelor...

    BRILINTA (Ticagrelor) Receives Additional Class I Recommendation in Updated ACCF/AHA Guidelines for the Management of STEMI Patients BRILINTA Recognized Across Major US Treatment Guidelines for ...

  4. FDA Is Set Decide the Fate of AstraZeneca's Heart Drug Brilinta

    www.aol.com/news/2010-12-15-fda-astrazeneca...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Medication discontinuation - Wikipedia

    en.wikipedia.org/wiki/Medication_discontinuation

    [1] [2] When initiated by the clinician, it is known as deprescribing. [3] Medication discontinuation is an important medical practice that may be motivated by a number of reasons: [4] [3] Reducing polypharmacy; Reducing health expenditure

  6. Thienopyridine - Wikipedia

    en.wikipedia.org/wiki/Thienopyridine

    Ticagrelor (Brilinta) is often listed with thienopyridine inhibitors and has similar indications for use but is not a thienopyridine. It is a cyclo-pentyltriazolo-pyrimidine that is distinct from the mechanism of the thienopyridines in that it reversibly (rather than irreversibly) inhibits the P2Y 12 receptor. [1]

  7. BRILINTA (ticagrelor) Launches "Complete the Course" — a ...

    www.aol.com/news/2012-09-19-brilinta-ticagrelor...

    For premium support please call: 800-290-4726 more ways to reach us more ways to reach us

  8. Bentracimab - Wikipedia

    en.wikipedia.org/wiki/Bentracimab

    Bentracimab is a monoclonal antibody medication which has been shown in phase one and two clinical trials to function as a reversal agent for the anti–blood clotting drug ticagrelor (which acts as a P2Y 12 inhibitor and is sold under the brand name Brilinta among others). [2]

  9. Antiplatelet drug - Wikipedia

    en.wikipedia.org/wiki/Antiplatelet_drug

    Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs can reversibly or irreversibly inhibit the process involved in platelet activation resulting in decreased tendency of platelets to adhere to one another ...